This announcement is a separate document:
Immuron Ltd: Travelan to progress to Phase 3 Clinical Trials in the US
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.